In fact, there are some SLC dysfunctions associated with CRC, such as L-type amino acid transporter 1 (LAT1) and alanine-serine-cysteine transporter 2 (ASCT2) upregulation, that may have an impact on disease aggressiveness [9,10,11]. The gene discussed is SLC1A5; the disease is colorectal carcinoma.